GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,489 | -4,853 | -633 | -371 | -501 |
| Depreciation Amortization | 2,781 | 1,637 | 190 | 121 | 691 |
| Accounts receivable | N/A | N/A | 35 | 10 | -40 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 84 | N/A |
| Other Working Capital | -221 | 387 | 230 | 88 | 477 |
| Other Operating Activity | 19,180 | 2,118 | 45 | -22 | -1,069 |
| Operating Cash Flow | $-1,749 | $-711 | $-133 | $-90 | $-442 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-6 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,589 | N/A | 89 | 50 | 433 |
| Debt Repayment | -6 | 1,329 | N/A | N/A | -8 |
| Financing Cash Flow | $2,583 | $1,329 | $89 | $50 | $425 |
| Beginning Cash Position | 43 | 43 | 43 | 43 | 123 |
| End Cash Position | 855 | 664 | 1 | 4 | 43 |
| Net Cash Flow | $812 | $621 | $-42 | $-39 | $-80 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,749 | -711 | -133 | -90 | -442 |
| Capital Expenditure | -6 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -1,755 | -711 | -133 | -90 | -442 |